3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
2
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Interventions
Idarubicin
2
Cytarabine
2
fludarabine phosphate
1
Thiotepa
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Mitoxantrone
1
Isotretinoin
1
Interferon-alpha
1
Idoxuridine
1
Drug Therapy
1
Bromodeoxyuridine
1
Biological Therapy
1
BI 6727
1
Arsenic Trioxide
1
Antilymphocyte Serum
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Leukemia, Monocytic, Acute
×
BI 6727
×
Clear all
NCT02527174
2017-04-05
VIAC
University of Alberta
Phase 1
Withdrawn